Hitoshi Shiozaki Selected Research

Hitoshi Shiozaki Research Topics

Disease

28	Neoplasms (Cancer) 01/2022 - 12/2000
16	Stomach Neoplasms (Stomach Cancer) 01/2014 - 12/2000
15	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 03/2002
8	Hepatocellular Carcinoma (Hepatoma) 12/2010 - 01/2003
6	Neoplasm Metastasis (Metastasis) 12/2013 - 04/2010
5	Esophageal Squamous Cell Carcinoma 02/2015 - 03/2002
5	Carcinoma (Carcinomatosis) 12/2013 - 03/2002
5	Lymphatic Metastasis 06/2010 - 12/2000
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2014 - 03/2002
4	Colorectal Neoplasms (Colorectal Cancer) 11/2011 - 11/2006
4	Rectal Neoplasms (Rectal Cancer) 03/2007 - 09/2004
3	Ascites 03/2011 - 05/2003
3	Breast Neoplasms (Breast Cancer) 10/2010 - 01/2004
3	Carcinogenesis 04/2007 - 03/2002
2	Neoplasm Micrometastasis 01/2022 - 07/2002
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2014
2	Neutropenia 01/2012 - 01/2004
2	Inflammation (Inflammations) 09/2011 - 01/2009
2	Duodenogastric Reflux 09/2011 - 04/2007
2	Esophagitis 09/2011 - 04/2007
2	Adenocarcinoma 06/2010 - 12/2000
2	Pancreatitis 05/2010 - 01/2009
2	Gallstones (Gallstone) 01/2010 - 01/2009
2	Lithiasis 01/2010 - 01/2008
2	Pleural Effusion (Pleural Effusions) 05/2004 - 01/2003
1	Malnutrition (Nutritional Deficiencies) 02/2015
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 05/2014
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2013
1	Hypersensitivity (Allergy) 04/2013
1	Peritoneal Neoplasms 01/2012
1	Surgical Wound Infection 01/2012
1	Gastroesophageal Reflux (GERD) 09/2011
1	Hyperplasia 09/2011
1	Peptic Esophagitis (Reflux Esophagitis) 09/2011
1	Ulcer 09/2011
1	Pathologic Constriction (Stenosis) 12/2010
1	Neuroblastoma 04/2010
1	Infections 01/2009

Drug/Important Bio-Agent (IBA)

7	Paclitaxel (Taxol)FDA LinkGeneric 12/2012 - 05/2003
6	Cisplatin (Platino)FDA LinkGeneric 04/2013 - 03/2002
5	OsteopontinIBA 11/2011 - 01/2009
5	Fluorouracil (Carac)FDA LinkGeneric 01/2011 - 03/2002
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2008
3	Protein Subunit VaccinesIBA 01/2022 - 11/2006
3	Peptides (Polypeptides)IBA 01/2022 - 11/2009
3	Cadherins (E-Cadherin)IBA 06/2002 - 12/2000
2	AntigensIBA 01/2022 - 01/2014
2	Monoclonal AntibodiesIBA 12/2013 - 12/2012
2	titanium silicide (TS-1)IBA 04/2013 - 09/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2012 - 01/2009
2	Glycoproteins (Glycoprotein)IBA 01/2010 - 01/2008
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2009 - 07/2002
2	Glutathione (Reduced Glutathione)IBA 04/2007 - 10/2005
2	DNA (Deoxyribonucleic Acid)IBA 07/2006 - 09/2004
1	VaccinesIBA 01/2022
1	Cancer VaccinesIBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Proline (L-Proline)FDA Link 05/2014
1	montanide ISA 51IBA 01/2014
1	Epithelial Cell Adhesion MoleculeIBA 12/2013
1	Tyrosine Kinase InhibitorsIBA 04/2013
1	Trastuzumab (Herceptin)FDA Link 12/2012
1	human ERBB2 proteinIBA 12/2012
1	HLA-DR Antigens (HLA-DR)IBA 01/2012
1	Rabeprazole (Aciphex)FDA Link 09/2011
1	Bile Acids and Salts (Bile Acids)IBA 09/2011
1	Therapeutic UsesIBA 03/2011
1	Docetaxel (Taxotere)FDA Link 01/2011
1	Capsules (Microcapsules)IBA 12/2010
1	Thymidylate SynthaseIBA 10/2010
1	N 30IBA 08/2010
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 05/2010
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 05/2010
1	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 04/2010
1	Angiogenesis InhibitorsIBA 04/2010
1	MucinsIBA 01/2010
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 09/2009
1	Biotin (Vitamin H)FDA Link 09/2009
1	CholesterolIBA 01/2009

Therapy/Procedure

13	Therapeutics 01/2022 - 06/2002
10	Drug Therapy (Chemotherapy) 05/2013 - 06/2002
8	Radiofrequency Ablation 12/2010 - 01/2003
7	Lymph Node Excision (Lymph Node Dissection) 12/2012 - 03/2002
5	Esophagectomy 02/2015 - 03/2002
4	Neoadjuvant Therapy 11/2014 - 09/2002
4	Gastrectomy 12/2012 - 04/2007
4	Chemoradiotherapy 06/2010 - 03/2002
4	Colonic Pouches (S Pouch) 03/2007 - 09/2004
3	Radiotherapy 04/2013 - 03/2002
2	Combination Drug Therapy (Combination Chemotherapy) 01/2011 - 09/2003
2	Oral Administration 11/2009 - 11/2006
1	Stents 11/2014
1	Molecular Targeted Therapy 04/2013
1	Intravenous Administration 09/2012
1	Parenteral Nutrition 01/2012
1	Enteral Nutrition (Feeding, Tube) 01/2012
1	Cautery 12/2010
1	Microspheres (Microsphere) 04/2010
1	Intraperitoneal Injections 04/2010